Neuraxis, INC Cash Flow Statement
NRXS|3 years of annual SEC 10-K data (FY2023-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 3 fiscal years. All figures from audited SEC 10-K filings.
Neuraxis, INC used $6M in operating cash flow and negative free cash flow of $6M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -10.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income | -$7.8M | -$14.6M | -$4.8M |
| Depreciation & Amortization | $59.5K | $40.7K | $37.1K |
| Operating Cash Flow | -$6.4M | -$6.7M | -$2.3M |
| Capital Expenditures | $31.1K | $30.8K | $1.4K |
| Free Cash Flow | -$6.5M | -$6.7M | -$2.3M |
| FCF Margin | -181.1% | -273.4% | -85.7% |